We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Snibe Co.,Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe) is a global leader in the IVD field, with 30 years o... read more Featured Products: More products

Download Mobile App





SNIBE Showcases Total Lab Automation and Diagnostic Platforms at ADLM 2026

By LabMedica International staff writers
Posted on 30 Jul 2026

SNIBE is presenting its latest in vitro diagnostic and laboratory automation solutions at ADLM 2026 in Anaheim, California, where attendees can visit the company at Booth 3814. More...

The exhibit highlights SNIBE’s focus on integrated diagnostic workflows spanning immunoassay, clinical chemistry, automation, and broader laboratory testing needs.

A central focus of the exhibit is SATLARS mini-T8, the newest member of SNIBE’s Total Laboratory Automation Solutions. Designed for laboratories with limited space, the system integrates pre-analytical and post-analytical sample handling within a compact 2.2 m² footprint. It automates the sample handling and analysis process from loading to storage, while supporting rapid turnaround through compatibility with SNIBE’s high-throughput analyzers.

SNIBE is also showcasing its integrated and high-throughput testing systems, including the Biolumi CX Solution-X10+C10, which combines the MAGLUMI X10 immunoassay analyzer with the Biossays C10 biochemistry analyzer. The system enables immunoassay, biochemical, and ISE testing from one sample loading process, reducing sample transfer steps and helping laboratories improve testing efficiency.

The company’s MAGLUMI X8 chemiluminescence immunoassay system is designed for medium- to large-volume laboratories, offering up to 600 tests per hour in a single module and up to 2,400 tests per hour when four modules are combined. SNIBE’s Biossays C10 biochemistry analyzer further supports high-throughput workflows, with up to 2,000 biochemistry tests per hour, 1,000 ISE tests per hour, whole-blood HbA1c testing, and connectivity with laboratory automation systems.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.